Slettebø H, Hirschberg H, Lindegaard K F
Department of Neurosurgery, Rikshopitalet, National Hospital, Oslo, Norway.
Acta Neurochir (Wien). 1993;122(3-4):231-5. doi: 10.1007/BF01405534.
We have evaluated the long-term results of percutaneous retrogasserian glycerol rhizotomy (PRGR) in 60 patients with classical trigeminal neuralgia. Complete initial pain relief was achieved in 93% of the patients. Numbness was initially reported by 3/4 of the patients and at follow-up by 1/3, while long-lasting dysaesthesias were an important side effect in 38% of previously untreated patients. The half-life of the method was 47 months in our material, and this figure compares favourably with other previously reported series. The method carries a significant risk of long-lasting and troublesome sensory disturbances. Another disadvantage of the method, reported in the present long-term study, was the high incidence of recurrent neuralgia. We are unable to identify predictors of recurrent neuralgia after PRGR, although major recurrences were more common in patients with unchanged facial sensation postoperatively. In conclusion, PRGR offers safe and reliable relief of pain in patients with trigeminal neuralgia. In spite of the high incidence of recurrence and of long-lasting dysaesthesias it is, in our opinion, the method of choice in the elderly, and particularly suitable for patients at high risk.
我们评估了60例典型三叉神经痛患者经皮半月神经节甘油注射切断术(PRGR)的长期效果。93%的患者最初实现了完全疼痛缓解。最初有3/4的患者报告有麻木感,随访时为1/3,而在38%既往未治疗的患者中,长期感觉异常是一个重要的副作用。在我们的研究资料中,该方法的半衰期为47个月,这一数字优于之前报道的其他系列。该方法存在长期且令人困扰的感觉障碍的重大风险。本长期研究报告的该方法的另一个缺点是复发神经痛的发生率高。尽管术后面部感觉未改变的患者中主要复发更常见,但我们无法确定PRGR后复发神经痛的预测因素。总之,PRGR为三叉神经痛患者提供了安全可靠的疼痛缓解。尽管复发率和长期感觉异常的发生率很高,但我们认为,它是老年人的首选方法,尤其适用于高危患者。